Thursday, March 3, 2016

Valeant Says Dermatology-Business Executive Departs

Valeant Pharmaceuticals International Inc. said Deb Jorn, a key executive in charge of its U.S. dermatology products, has left the company for personal reasons.

from WSJ.com: US Business http://ift.tt/1OTJc3l
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)